RealSeq Secures Seed Financing to Advance the RiboMarkerTM Diagnostic Platform
/
DateJul 27 2023
Next Gen RNA fragmentomics-based diagnostics SANTA CRUZ, CALIFORNIA, UNITED STATES, July 27, 2023/EINPresswire.com/ — RealSeq Biosciences, Inc., a company developing RNA fragmentomics as real-time diagnostics... Read More →


















